Results 51 to 60 of about 4,527 (138)

Surgical Synergy in Primary Open-Angle Glaucoma: Assessing Safety and Efficacy of Hydrus, iStent, and Gonioscopy-Assisted Transluminal Trabeculotomy in Glaucoma Management. [PDF]

open access: yesJ Clin Med
Background/Objectives: This paper will compare the outcomes—safety and efficacy—of three minimally invasive glaucoma surgeries (MIGSs),the Hydrus Microstent, iStent, and Gonioscopy-Assisted Transluminal Trabeculotomy (GATT), for intraocular ...
Ayoub MZM, Al-Nahrawy A.
europepmc   +2 more sources

Canaloplasty: A Minimally Invasive and Maximally Effective Glaucoma Treatment

open access: yesJournal of Ophthalmology, Volume 2015, Issue 1, 2015., 2015
Canaloplasty is a highly effective, minimally invasive, surgical technique indicated for the treatment of open‐angle glaucoma that works by restoring the function of the eye’s natural outflow system. The procedure’s excellent safety profile and long‐term efficacy make it a viable option for the majority of glaucoma patient types.
Mahmoud A. Khaimi, Jens Funk
wiley   +1 more source

Exploring Glaucoma: From Pathogenesis to Emerging Diagnostic and Management Strategies

open access: yesJournal of Ophthalmology, Volume 2025, Issue 1, 2025.
Glaucoma is a leading cause of irreversible blindness globally, affecting millions of individuals. It encompasses a group of progressive optic neuropathies characterized by retinal ganglion cell loss and visual field deterioration, often associated with elevated intraocular pressure.
Rajesh Kumar Goit, Nilufer Yesilirmak
wiley   +1 more source

A Comparison of Endothelial Cell Loss in Combined Cataract and MIGS (Hydrus) Procedure to Phacoemulsification Alone: 6‐Month Results

open access: yesJournal of Ophthalmology, Volume 2015, Issue 1, 2015., 2015
Purpose. To compare the corneal endothelial cell loss after phacoemulsification, alone or combined with microinvasive glaucoma surgery (MIGS), in nonglaucomatous versus primary open angle glaucoma (POAG) eyes affected by age‐related cataract. Methods. 62 eyes of 62 patients were divided into group 1 (n = 25, affected by age‐related cataract) and group ...
Antonio M. Fea   +8 more
wiley   +1 more source

Comparison of Safety and Efficacy of Hydrus and iStent Combined with Phacoemulsyfication in Open Angle Glaucoma Patients: 24-Month Follow-Up

open access: yes, 2023
The paper presents the results of a 24-month-long observation comparing the effectiveness and safety of two micro-invasive glaucoma surgery (MIGS) devices: Hydrus Microstent and iStent Trabecular Bypass in combination with cataract phacoemulsification in
Marek Tadeusz Rękas   +2 more
core   +1 more source

A New Polymeric Minimally Invasive Glaucoma Implant

open access: yesAdvanced Materials Technologies, Volume 9, Issue 9, May 6, 2024.
A novel glaucoma implant–minimally invasive, polymeric, and potentially biodegradable–is presented. Made of a unique thermoplastic using replica molding, this device addresses common postoperative complications associated with rigid metallic implants. The potential biodegradability of the implant after implantation suggests a promising new approach for
Inês C.F. Pereira   +8 more
wiley   +1 more source

Update on Minimally Invasive Glaucoma Surgery (MIGS) and New Implants

open access: yesJournal of Ophthalmology, Volume 2013, Issue 1, 2013., 2013
Traditional glaucoma surgery has been challenged by the advent of innovative techniques and new implants in the past few years. There is an increasing demand for safer glaucoma surgery offering patients a timely surgical solution in reducing intraocular pressure (IOP) and improving their quality of life.
Lívia M. Brandão   +2 more
wiley   +1 more source

Pathological Mechanism and Clinical Therapy Progress of Schlemm’s Canal

open access: yesJournal of Ophthalmology, Volume 2024, Issue 1, 2024.
Schlemm’s canal (SC) is a small circular canal in the deep part of the sclera at the junction of the sclera and cornea. As an integral component of the aqueous humor outflow, its structure and function are essential in regulating intraocular pressure (IOP).
Yasha Zhou   +6 more
wiley   +1 more source

Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm’s Canal Microstent in Combination Cataract and Glaucoma Surgery [PDF]

open access: yes, 2022
PURPOSE: To present the 5-year results of the HORIZON trial comparing cataract surgery (CS) combined with an intracanalicular microstent with CS alone. DESIGN: Prospective, multicenter, controlled randomized clinical trial.
Singh, Kuldev   +8 more
core   +1 more source

Miniaturization in Glaucoma Monitoring and Treatment: A Review of New Technologies That Require a Minimal Surgical Approach

open access: yesOphthalmology and Therapy, 2019
In the management of glaucoma, recent and upcoming innovations have the potential to contribute to both the efficacy of intraocular pressure (IOP) monitoring and the number of available treatment options.
H. Burkhard Dick   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy